News Room

RSS

News Room provides integrated information to the media. In some instances, information on products or drug candidates under development may be included, but this is intended for members of the media, shareholders, and investors. The information is not intended for promotional or advertising purposes, or as medical advice, etc.

The Latest Media Conference

Chugai Open Innovation Meeting

Presentations:

Chugai’s Open Innovation in Drug Discovery
Dr. Tomoyuki Igawa,
Vice President, Head of Research Div., Chugai Pharmaceutical Co., Ltd.
Chugai Venture Fund: Investment Overview
John Gustofson,
Head of Chugai Venture Fund, LLC
Chugai’s Partnering Activities
Yumiko Asano,
Head of Partnering Dept., Chugai Pharmaceutical Co., Ltd.

News

01

Topics about Advanced and sustainable patient-centric healthcare

We introduce Chugai's initiatives for "Patient-Centric," which we uphold as our highest priority "Core Value.

Supporting the Cervical Cancer Elimination Program in Marshall Islands and Fiji

  • Sustainable Patient-Centric Healthcare
  • Global Health
  • Social Contribution

Elimination of cervical cancer and related morbidity and mortality in the context of Universal Health Coverage in Bhutan

  • Sustainable Patient-Centric Healthcare
  • Global Health
  • Social Contribution

The 5th Workshop on Multidisciplinary Team Care for Healthcare Professionals in Cambodia

  • Sustainable Patient-Centric Healthcare
  • Global Health
  • Social Contribution

Support for a remote ophthalmology screening project in Cambodia

  • Sustainable Patient-Centric Healthcare
  • Global Health
  • Social Contribution

Programs aimed at fostering a culture of internal recognition and encouraging employee participation in social contribution activities

  • Sustainable Patient-Centric Healthcare
  • Social Contribution
  • Social Welfare
  • Inclusive Society
  • Next Generation Development
  • Local Communities

Supporting the Project for Eliminating Cervical Cancer Toward the Promotion of UHC in Bhutan

  • Sustainable Patient-Centric Healthcare
  • Global Health
  • Social Contribution

The 4th　Online Workshop on Multidisciplinary Team Care for Healthcare Professionals in Cambodia

  • Sustainable Patient-Centric Healthcare
  • Global Health
  • Social Contribution

Chugai Life Science Park Yokohama received a letter of appreciation from the Japanese Red Cross Society for its contribution to the promotion of blood donation activities

  • Sustainable Patient-Centric Healthcare
  • Social Contribution
02

Topics about Innovation

Every employee is committed to pursuing innovation that only we can do to realize "advanced and sustainable patient-centric healthcare"

  • #Digital Technology
  • #Open Innovation
  • #Co-Creation

CHUGAI INNOVATION DAY 2024 Report—More Than 3,000 in Attendance

Chugai Pharmaceutical’s CHUGAI INNOVATION DAY 2024 was hosted on November 25 (Mon) and 26 (Tue), 2024. This was the fifth hosting of the CHUGAI INNOVATIO

  • Innovation
  • R&D
  • DX
  • Event
  • #Digital Technology
  • #Co-Creation

Takao Suzuki was previously an employee at Microsoft where he supported numerous companies as director of the DX strategy advisory department. He now works as Head of the DX Unit at Chugai Pharmaceutical. According to Suzuki, what are the key factors to ensuring the successful implementation of DX?

Aiming to become the top innovator in the healthcare industry, Chugai Pharmaceutical has positioned DX as a fundamental element of its growth strategy. Phase 1

  • Innovation
  • DX
  • CHUGAI DIGITAL VISION 2030
  • Top Interview
  • #Science and Technology
  • #Digital Technology
  • #Sustainability

Greater Efficiency in Bioprocess Development. Digital Transformations in Pharmaceuticals

Chugai Pharmaceutical is currently promoting companywide DX to achieve the targets of its new growth strategy Top I 2030. The company is focusing on innovative

  • Innovation
  • R&D
  • DX
  • Sustainability
  • CHUGAI DIGITAL VISION 2030
  • Production Technology
  • #Science and Technology

Working to Reform the Drug Discovery Process—Acceleration of Drug Discovery Research Using Cryo-EM

Torizawa is general manager of the Protein Science Research Department. He is currently in charge of the early stages of drug discovery to uncover molecules th

  • Innovation
  • R&D
  • Cryo-Electron Microscopy
  • #Science and Technology
  • #Digital Technology

Working Toward Greater Efficiency in the Drug Discovery Process for Mid-size Molecules. Development of a Crystallization Confirmation App Using Agile Development Methods

Agile development has recently been garnering attention as a method that involves quickly ascertaining needs and progressing with a project in an agile and fle

  • Innovation
  • R&D
  • DX
  • Mid-Molecule Pharmaceuticals
  • #Science and Technology

From the medical frontlines to a pharmaceutical company. Medical doctors leveraging their clinical experience to contribute to the creation of pharmaceuticals

Chugai Pharmaceutical, with its R&D bases and global development functions in Japan, has strived to conduct clinical studies based on medical grounds and o

  • Innovation
  • R&D
  • Recruitment
  • Human Resources
  • #Science and Technology
  • #Digital Technology

Maximizing Drug Discovery Through Team Capabilities. Delivering Innovative Drugs to Patients with Process and Technological Development

Kondo is an employee at the pharmaceutical research department. Within his group, in addition to overseeing process development and manufacturing technology tr

  • Innovation
  • R&D
  • DX
  • Recruitment
  • Mid-Molecule Pharmaceuticals
  • Production Technology
03

Topics about Sustainability

We will introduce our latest activities aimed at solving social issues through our business operations, in pursuit of "creating shared value" with society.

Support for Children’s Performance of “Momotaro:”

  • Social Contribution
  • Next Generation Development
  • Local Communities

Support for Children’s Performance of “The Three Little Pigs”

  • Social Contribution
  • Next Generation Development
  • Local Communities

Roche Children’s Walk 2018

  • Social Contribution
  • Social Welfare

Charity Sale to Support the Great East Japan Earthquake and the 2016 Kumamoto Earthquake

  • Social Contribution
  • Social Welfare
  • Local Communities

Exhibiting at the Nihonbashi Kid’s Town! 2018 “Experience Real Jobs” Event

  • Social Contribution
  • Next Generation Development
  • Local Communities

Participating in the 48th Annual Cleaning of the Famed Nihonbashi Bridge

  • Social Contribution
  • Local Communities

Biology Lab Classes for Children Held (2018)

  • Social Contribution
  • Next Generation Development

2018 Private Sector Training for Teachers Held

  • Social Contribution
  • Next Generation Development
04

Pickup Contents

Features of the Strategic Alliance and Business Model “Alliance with Roche”

Features of the Strategic Alliance and Business Model “Transactions with Roche”

Press Room

Resources for the Media including press releases, presentation slides, videos and other materials are available.

Features of the Strategic Alliance and Business Model “Alliance with Roche”（7:04）

Features of the Strategic Alliance and Business Model “Alliance with Roche”

In 2002, Chugai started a strategic alliance with the Swiss company Roche, one of the world’s leading pharmaceutical companies. Under its unique business model, Chugai has realized its continuous growth.

While a member of the Roche Group, Chugai maintains its autonomous management and listing on the Tokyo Stock Exchange, enabling Chugai to focus on innovation with an emphasis on originality. This unprecedented business model contributes to enhancing Chugai’s corporate value and developing the Roche Group.

In this video, we will show the strategic alliance with Roche that forms the basis for this unique business model.

Features of the Strategic Alliance and Business Model “Transactions with Roche”（12:43）

Features of the Strategic Alliance and Business Model “Transactions with Roche”

In 2002, Chugai started a strategic alliance with the Swiss company Roche, one of the world’s leading pharmaceutical companies.
Under its unique business model, Chugai has realized its continuous growth.

In this video, we will present the financial impact that transactions with Roche under the strategic alliance have on Chugai.
The explanation will be divided into two parts: “out-licensing of in-house products to Roche” and “in-licensing of products from Roche.”

View in Japanese